Glycemic efficacy
From Infogalactic: the planetary knowledge core
Lua error in package.lua at line 80: module 'strict' not found. Glycemic efficacy refers to the capacity of regulated glycemic levels to produce an effect in people with diabetes and heart disease.[1] According to Zeev Vlodaver, Robert F. Wilson and Daniel J. Garry, "exenatide and liraglutide are synthetic GLP-1 agonists and have demonstrated glycemic efficacy (HbA1c reductions of between 0.7 and 2%) associated with mild weight loss."[2] Glyburide, metformin and rosiglitazone have been assessed as a monotherapy in the durability of glycemic efficacy.[3]
